Bonsai Biotherapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.68K

  • Investors
  • 2

Bonsai Biotherapeutics General Information

Description

Developer of tolerogen-based biological drugs designed to restore immune tolerance and provide disease-modifying relief for autoimmune conditions. The company offers a tolerogen platform that utilizes targeted immune reprogramming rather than broad immunosuppression, enabling clients to achieve long-lasting therapeutic balance while maintaining their normal immune system capacity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Arvid Wallgrens backe 20
  • 8th floor
  • 413 46 Gothenburg
  • Sweden
+46 076-319
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • Arvid Wallgrens backe 20
  • 8th floor
  • 413 46 Gothenburg
  • Sweden
+46 076-319

Bonsai Biotherapeutics Timeline

2026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bonsai Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Apr-2026 $2.68K Completed Generating Revenue
1. Early Stage VC 01-Apr-2026 Completed Generating Revenue
To view Bonsai Biotherapeutics’s complete valuation and funding history, request access »

Bonsai Biotherapeutics Patents

Bonsai Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260207722-A1 Combination for treatment of autoimmune diseases Pending 09-Mar-2023
US-20240270816-A1 Fusion protein for treating myasthenia gravis Pending 07-Jun-2021

Bonsai Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bonsai Biotherapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Flerie Venture Capital Minority
Vinnova Government
To view Bonsai Biotherapeutics’s complete investors history, request access »

Bonsai Biotherapeutics FAQs

  • When was Bonsai Biotherapeutics founded?

    Bonsai Biotherapeutics was founded in 2025.

  • Where is Bonsai Biotherapeutics headquartered?

    Bonsai Biotherapeutics is headquartered in Gothenburg, Sweden.

  • What is the size of Bonsai Biotherapeutics?

    Bonsai Biotherapeutics has 7 total employees.

  • What industry is Bonsai Biotherapeutics in?

    Bonsai Biotherapeutics’s primary industry is Biotechnology.

  • Is Bonsai Biotherapeutics a private or public company?

    Bonsai Biotherapeutics is a Private company.

  • What is Bonsai Biotherapeutics’s current revenue?

    The current revenue for Bonsai Biotherapeutics is .

  • Who are Bonsai Biotherapeutics’s investors?

    Flerie and Vinnova have invested in Bonsai Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process